Neurosurgery News and Research

RSS

New protocol to tackle postpartum depression

Up to 80 percent of women experience depressive symptoms postpartum, with one in eight reporting the emergence of major depression within weeks of delivery.

10 Sep 2009

St. Jude Medical's Brio neurostimulator receives CE Mark approval

St. Jude Medical, Inc. (NYSE:STJ) today announced CE (Conformité Européenne) Mark approval of the Brio™ neurostimulator, the world’s smallest, longest-lasting rechargeable deep brain stimulation (DBS) device for treating the symptoms of Parkinson’s disease. A 67-year-old man who has suffered from Parkinson’s disease for more than 26 years became the first person to be implanted with the Brio neurostimulator.

9 Sep 2009

A voluntary recall program announced by CONMED Linvatec

CONMED Corporation's (NASDAQ: CNMD) CONMED Linvatec unit announced today a voluntary recall for certain model numbers of the PRO5 & PRO6 series battery handpieces manufactured prior to May 31, 2008, and certain lots of the MC5057 Universal Cable manufactured prior to December 1, 2006 used with certain of CONMED Linvatec's electric powered handpieces.

9 Sep 2009

Misleading information in hospital report cards can impact patients’ health care

A key statistic that consumer groups and the media often use when compiling hospital report cards and national rankings can be misleading, researchers report in a new study.

9 Sep 2009

CARO and Elekta award $75,000 fellowship for lung cancer research

The Canadian Association of Radiation Oncology (CARO), along with international medical-technology group Elekta, are pleased to award the 2009 CARO-Elekta Research Fellowship to Radiation Oncologist, Dr. David Palma.

From Elekta 5 Sep 2009

Proton Therapy facility in Prague to implement Elekta's information management systems

Elekta (STO:EKTAB) will provide treatment planning and information management systems for a major Proton Therapy facility in Prague, Czech Republic. The software solutions will facilitate the highest quality of patient care and lead to improved clinical efficiency.

From Elekta 5 Sep 2009

IMRIS sells IMRISneuro to Le Bonheur Children's Medical Center

IMRIS Inc. (TSX: IM) ("IMRIS" or the "Company") today announced the sale of its flagship product, IMRISneuro, to Le Bonheur Children's Medical Center.

4 Sep 2009

Top cancer hospitals have Elekta solutions for information management

Banner Good Samaritan treats cancers and neurological disorders with the Novalis Tx radiosurgery platform

John J. Kresl, M.D., Ph.D., and colleagues at Banner Good Samaritan Medical Center are now treating a wide variety of cancers and neurological disorders with highly-accurate, non-invasive, image-guided radiosurgery using the Novalis Tx(TM) radiosurgery platform from Varian Medical Systems (NYSE: VAR) and BrainLAB.

4 Sep 2009

New treatment for vaso-occlusive crisis in sickle cell patients

GlycoMimetics, Inc. (GMI), a clinical-stage biotechnology company that is developing a new class of glycobiology-based therapies for a broad range of indications, today announced that a pilot study of the company’s lead candidate, GMI-1070, is underway in sickle cell patients. The first patients in this pilot study were treated at Children’s Hospital & Research Center Oakland in California.

4 Sep 2009

Optimized turmeric extracts may prevent memory loss

scientists with HerbalScience Group LLC, working with researchers from other organizations and medical institutions, conducted an in-depth study of optimized turmeric extracts, demonstrating that key bioactives in the botanical extracts inhibit aggregation and release of amyloid, a protein fragment considered a prime causal suspect in Alzheimer's disease.

3 Sep 2009

Elekta Holdings appoints new CEO

James Hoey has been named CEO of Elekta Holdings with overall responsibility for all of Elekta’s North American legal entities. He will also assume responsibility for Region North America, replacing Joseph Jachinowski who has decided to leave the company for an external position.

From Elekta 3 Sep 2009

Interim Phase II data of Cotara reveals signs of efficacy in GBM patients

Peregrine Pharmaceuticals, Inc. today reported that clinical investigators are presenting interim Phase II data showing that its brain cancer agent Cotara(R) appeared well tolerated and demonstrated encouraging signs of efficacy in patients with glioblastoma multiforme (GBM), the deadliest form of brain cancer.

3 Sep 2009

Wallet-sized cards offer athletes tips for detecting and monitoring concussions

In response to a rising number of concussions and recent research which shows young athletes with repeated brain injuries are at great risk for future neurological problems, the Illinois Athletic Trainers Association (IATA) and the Chicago Institute of Neurosurgery and Neuroresearch (CINN) are offering a wallet-sized card with tips for detecting and monitoring concussions. The complimentary card is an educational tool for parents, coaches and others who work with young athletes to help them identify signs of a concussion.

2 Sep 2009

BRNI announces agreement to advance research on brain and neurological disorders

The Blanchette Rockefeller Neurosciences Institute (BRNI) announced today an agreement with a group of neurological specialists (Brain Injury Group) to examine possible confluences of the Group's work with brain injuries, head trauma, and strokes and BRNI's research.

2 Sep 2009

Misonix commences direct to hospital sales of its SonaStar Ultrasonic Surgical Aspirator in the US

Misonix, Inc., (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, today announced the second expansion of its direct sales channel for the United States, which was first disclosed in June 2008.

2 Sep 2009

Children's Hospital Oakland converts to Masimo Rainbow SET Pulse CO-Oximetry technology

Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, announced today that Children's Hospital & Research Center Oakland has completed its system-wide conversions to Masimo Rainbow SET Pulse CO-Oximetry technology.

2 Sep 2009

New director appointed at the Saint John’s Neuroscience Institute

Saint John’s Health Center today announced the appointment of world-renowned neurosurgeon Amin Kassam, MD, as Director of the new Saint John’s Neuroscience Institute and faculty member of the John Wayne Cancer Institute at Saint John’s. Dr. Kassam will lead the development of the new Neuroscience Institute which will offer an international minimally invasive neurosurgery center, as well as neuro-oncology, neuro-vascular surgery and other neuroscience services.

31 Aug 2009

Spinal implant developed by Sanfor Clinic neurosurgeon receives FDA market clearance

Sanford Health, a comprehensive health care provider in the Upper Midwest, announced today a spinal implant developed by Sanford Clinic Neurosurgeon, Wilson Asfora, MD, Sanford Clinic Neurosurgery & Spine, has received United States Food and Drug Administration (FDA) 510(k) market clearance as a lumbar intervertebral body fusion device.

31 Aug 2009

FDA provides marketing clearance for the spinal implant developed by Sanford Health

28 Aug 2009

Neurosurgery News and Research

New protocol to tackle postpartum depression

St. Jude Medical's Brio neurostimulator receives CE Mark approval

A voluntary recall program announced by CONMED Linvatec

Misleading information in hospital report cards can impact patients’ health care

CARO and Elekta award $75,000 fellowship for lung cancer research

Proton Therapy facility in Prague to implement Elekta's information management systems

IMRIS sells IMRISneuro to Le Bonheur Children's Medical Center

Top cancer hospitals have Elekta solutions for information management

Banner Good Samaritan treats cancers and neurological disorders with the Novalis Tx radiosurgery platform

New treatment for vaso-occlusive crisis in sickle cell patients

Optimized turmeric extracts may prevent memory loss

Elekta Holdings appoints new CEO

Interim Phase II data of Cotara reveals signs of efficacy in GBM patients

Wallet-sized cards offer athletes tips for detecting and monitoring concussions

BRNI announces agreement to advance research on brain and neurological disorders

Misonix commences direct to hospital sales of its SonaStar Ultrasonic Surgical Aspirator in the US

Children's Hospital Oakland converts to Masimo Rainbow SET Pulse CO-Oximetry technology

New director appointed at the Saint John’s Neuroscience Institute

Spinal implant developed by Sanfor Clinic neurosurgeon receives FDA market clearance

FDA provides marketing clearance for the spinal implant developed by Sanford Health

Neuroscience - Second Edition eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News